Latest stories on ALMR
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Business Insider56 · neutralgeneral
Alamar Biosciences, Inc. (ALMR) files 8-K
SEC 8-K50 · neutralgeneral
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Alamar Biosciences: Promising But Expensive Proteomics Growth
Seeking Alpha58 · neutralgeneral
Alamar Biosciences: The Content Flywheel Is More Valuable Than The Instrument
Seeking Alpha73 · bullishproduct/pr
Stifel raises Alamar Biosciences stock price target on earnings beat
Investing.com Analyst Ratings61 · neutralanalyst
Alamar Biosciences price target raised to $31 from $30 at BofA
The Fly61 · neutralanalyst
Alamar Biosciences price target raised to $32 from $28 at Stifel
The Fly63 · neutralanalyst
Alamar Biosciences price target raised to $35 from $32 at JPMorgan
The Fly63 · neutralanalyst
Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through
Seeking Alpha67 · bullishearnings
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Alamar Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Alamar Biosciences Expands Alzheimers Data Initiative Deal With 86k Samples
The Fly63 · neutralproduct/pr
Alamar Biosciences Sees Fy26 Revenue 116m 120m Consensus 113 22m
The Fly63 · neutralearnings
Alamar Biosciences reports Q2 EPS (22c), consensus (32c)
The Fly34 · bearishearnings
Alamar Biosciences, Inc. GAAP EPS of -$0.22 beats by $0.11, revenue of $29.4M beats by $3.46M
Seeking Alpha68 · bullishearnings
Alamar Biosciences, Inc. (ALMR) files 8-K
SEC 8-K50 · neutralgeneral
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
StockTitan56 · neutralearnings
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
StockTitan63 · neutralproduct/pr
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
StockTitan63 · neutralproduct/pr
Alamar Biosciences, Inc. (ALMR) files 8-K
SEC 8-K50 · neutralgeneral
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
Business Insider50 · neutralgeneral